Dr. Agarwal’s Hospitals Unveil Revolutionary DNA Imaging Technology

Bengaluru: A groundbreaking achievement is currently underway for Karnataka’s medical research community. Dr. Agarwal’s Hospitals and the Gene Research Institute  inaugurated a state-of-the-art contrast microscope, poised to revolutionize genetic research and DNA expertise. The advanced equipment inaugurated by actress Angana. In the presence of Swami Chaitanyanand Saraswati, Chairman of Srisiim Bharati UN representative. This initiative highlights the state's commitment to scientific innovation and progress. 

This advanced microscope, utilizing the proprietary Morpho Genetic Activator of Nucleic Acids (MANA) technology, marks a significant milestone in the 21-year journey of the institution, which has treated over 20,000 patients. With this revolutionary approach, scientists will be able to transform every drop of a patient’s blood into healthy embryonic DNA and stem cells. This breakthrough paves the way for more personalized treatments, even for previously untreatable conditions. 

"Every disease is a transformation of DNA," a fact proven through four generations and over 100 years of medical research. Dr. Sunita Rana Agarwal, who leads this groundbreaking technological advancement, explains that the new microscope’s live-cell imaging capability allows researchers to accurately identify healthy DNA and operate at a micron-level precision. This makes it possible to directly target disease sites with unprecedented accuracy. 

The instrument brings hope for overcoming limitations of conventional medicine. It has already shown remarkable success in treating challenging conditions such as retinitis pigmentosa, cerebral degeneration, arthritis, optic degeneration, and various genetic DNA mutations. 

As Karnataka emerges as a leader in genetic medicine, this collaboration between scientific innovation and clinical applications demonstrates the extraordinary achievements of dedicated researchers. This milestone signifies a revolutionary step forward in tackling future medical challenges.